The Stop TB Partnership launches the second of two online consultations to inform the development of the new Global Plan to End TB for the period 2023 to 2030.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

Mycobacteria are a group of pathogenic bacteria that cause diseases like leprosy and tuberculosis in humans. Now, a new study by scientists at Hiroshima University finds that mycobacteria are associated with red blood cells at lung infection sites, an interaction that has escaped scientific notice for 140 years since the discovery of the organism causing tuberculosis.

The McGill Summer Institutes in Global Health announced its 2022 TB summer courses. You can submit your application now! Prices increase after 6 May 2022.

Aidspan published a special issue of the Global Fund Observer, covering aspects of the Ukrainian-Russian conflict and its impact, both domestic and beyond. It particularly focuses on maintaining essential live-saving services for HIV and TB.

GENEVA, 28 March 2022 – The Global Fund to Fight AIDS, Tuberculosis and Malaria enthusiastically welcomes President Joe Biden’s request to the United States Congress for a commitment of US$2 billion for the Global Fund for fiscal year 2023, the first year of the Global Fund’s 2023-2025 funding cycle. President Biden’s fiscal year 2023 budget includes “… a $2 billion contribution for the Global Fund’s Seventh Replenishment, for an intended pledge of $6 billion over three years….” The White House notes that the United States will “match $1 for every $2 contributed by other donors.”

Episode 5 of the podcast series, The Dose, by the Stop TB Partnership's Working Group on New TB Drugs (WGND) is now available online. Shobha Shukla speaks with two experts on highly drug-resistant TB, Dr. Francesca Conradie and Dr. Gustavo Velásquez, on the results from ZeNix, a Phase 3 clinical trial exploring potential optimization of a regimen for treating patients with highly drug-resistant TB.

The German Respiratory Society (DGP) is expecting patients with tuberculosis (TB) to be among the war refugees from Ukraine. "Therefore, it must be ensured that these people continue to be medically treated without any breaks, so that their treatment is successful," said Torsten Bauer, MD, in a press release from the DGP and the German Central Committee Against Tuberculosis (DZK). Bauer is president of the DGP and DZK, as well as chief physician of the Heckeshorn Pulmonary Clinic in Berlin.

Wave 10 to focus on two new areas: Integrated TB service delivery and TB preventive treatment.

Indonesian G20 Presidency TB event presents a multicomponent approach to finance the TB response and prepare the world for future pandemics.